These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8657506)

  • 1. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin].
    Lauterbach R; Kachlik P; Pawlik D; Bajorek I
    Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
    Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
    An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity.
    Bader D; Kugelman A; Maor-Rogin N; Weinger-Abend M; Hershkowitz S; Tamir A; Lanir A; Attias D; Barak M
    J Perinatol; 2001 Jun; 21(4):215-20. PubMed ID: 11533837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P; Shankaran S; Krishnan RG
    J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of recombinant human erythropoietin in the treatment of anemia of prematurity].
    Rosati E; Latini G; De Mitri B; Quartulli L; Caliandro P
    Pediatr Med Chir; 1995; 17(1):45-8. PubMed ID: 7739926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study comparing recombinant erythropoietin alone with erythropoietin plus recombinant granulocyte-macrophage colony-stimulating factor for treatment of the anemia of prematurity.
    Christensen RD; Hunter DD; Ohls RK
    J Perinatol; 1994; 14(2):110-3. PubMed ID: 8014692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-term erythropoietin therapy in anemic premature infants.
    Reiter PD; Rosenberg AA; Valuck R; Novak K
    J Perinatol; 2005 Feb; 25(2):125-9. PubMed ID: 15526012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity.
    Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].
    Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J
    An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity.
    Bader D; Blondheim O; Jonas R; Admoni O; Abend-Winger M; Reich D; Lanir A; Tamir A; Eldar I; Attias D
    Acta Paediatr; 1996 Apr; 85(4):496-501. PubMed ID: 8740313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
    Meyer MP; Haworth C; Meyer JH; Commerford A
    J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.
    Giannakopoulou C; Bolonaki I; Stiakaki E; Dimitriou H; Galanaki H; Hatzidaki E; Kalmanti M
    Pediatr Hematol Oncol; 1998; 15(1):37-43. PubMed ID: 9509504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants.
    Schneider JK; Gardner DK; Cordero L
    Pharmacotherapy; 2008 Nov; 28(11):1335-40. PubMed ID: 18956993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
    Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
    Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.